Doxil and Herpes simplex - a phase IV clinical study of FDA data

Summary:

Herpes simplex is reported as a side effect among people who take Doxil (doxorubicin hydrochloride), especially for people who are female, 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Herpes simplex when taking Doxil. It is created by eHealthMe based on reports of 10,418 people who have side effects when taking Doxil from the FDA, and is updated regularly.

What is Doxil?

Doxil has active ingredients of doxorubicin hydrochloride. It is often used in ovarian cancer. eHealthMe is studying from 10,479 Doxil users. Check the latest studies of Doxil.

What is Herpes simplex?

Herpes simplex (herpes simplex is a common viral infection) is found to be associated with 715 drugs and 895 conditions by eHealthMe. Check the latest studies of Herpes simplex.

On Jul, 14, 2026

10,418 people reported to have side effects when taking Doxil.
Among them, 30 people (0.29%) have Herpes simplex.

Among these 30 people:

What is the gender of people who have Herpes simplex when taking Doxil? *

female: 72.41 %
male: 27.59 %

What is the age of people who have Herpes simplex when taking Doxil? *

What are other drugs people take besides Doxil? *

What are other side effects people have besides Herpes simplex? *

Weakness: 19 people, 63.33%
Fatigue (feeling of tiredness): 19 people, 63.33%
Headache (pain in head): 17 people, 56.67%
Cellulitis (infection under the skin): 16 people, 53.33%
Neuropathy Peripheral (surface nerve damage): 16 people, 53.33%
Pain: 16 people, 53.33%
Pain In Jaw: 16 people, 53.33%
Metastases To Lung (cancer spreads to lung): 16 people, 53.33%
Metastases To Bone (cancer spreads to bone): 16 people, 53.33%
Dyspnea (difficult or laboured breathing): 16 people, 53.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 10.00%
Breast Cancer: 2 people, 6.67%
Breast Cancer Metastatic: 2 people, 6.67%
Undifferentiated Sarcoma (undifferentiated cancer): 1 person, 3.33%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 3.33%
Bone Marrow Conditioning Regimen: 1 person, 3.33%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 3.33%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 3.33%
Conjunctivitis (pink eye): 1 person, 3.33%
Indigestion: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Doxil and have Herpes simplex?

- Check whether Herpes simplex is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doxil:

Doxil (10,479 reports)

Herpes simplex treatments and more:

Herpes simplex (13,420 reports)

Browse all side effects of Doxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Herpes simplex:

Herpes simplex (715 drugs)

Browse all the conditions that are associated with Herpes simplex:

Herpes simplex (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Doxil) and Doxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.